A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease — Stella

Recruiting

Back to Still's Disease, Adult-Onset trials

Trial locations(1 site)

China

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality

Key details

Sponsor

Ruijin Hospital

Enrollment target

~20 participants

Started

September 2025

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov